Osteoporosis menopausica: tratamiento, revision narrativa.
Resumen
La osteoporosis es clínicamente importante debido a que es el factor de riesgo más importante para las fracturas. Las fracturas por osteoporosis de la cadera, columna, y ante brazos están asociadas a la limitación para caminar, contribuye a deformidad física, dolor crónico, pérdida de la independencia, y disminución de la calidad de vida en todo el mundo.
Citas
Chandran M, McCloskey EV, Thu WPP, et al. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 2018; 13:130.
Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2016;374:254-62. Erratum in: N Engl J Med 2016; 374:1797.
Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 2020; 26:564-70.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392:1789-858. Erratum in: Lancet 2019;
:e44.
Viswanathan M, Reddy S, Berkman N, et al. Screening to prevent osteoporotic fractures: updated evidence report and systematic review for the US Preventive Services Task
Force. JAMA 2018; 319:2532-51.
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. Arch. Osteoporos 2013; 8,136.
Yong EL, Ganesan G, Kramer MS, et al. Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium. Osteoporos Int 2019; 30:879-86.
Yong EL, Ganesan G, Kramer MS, et al. Risk factors and trends associated with mortality among adults with hip fracture in Singapore. JAMA Netw Open 2020; 3:e1919706.
World Population Ageing 2017: Highlights. New York (NY): United Nations (UN) Department of Economic and Social Affairs; 2017.
Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women’s Health Across the Nation (SWAN). J Bone Miner Res 2012; 27:111-8.
Nikitovic M, Wodchis WP, Krahn MD, et al. Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporos Int. 2013; 24:659–669.
Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol 2014; 142:155-70.
Thu WPP, Logan SJS, Cauley JA, Kramer MS, Yong EL. Ethnic differences in bone mineral density among midlife women in a multi-ethnic Southeast Asian cohort. ArchOsteoporos 2019; 14:80.
Adler RA, El-Hajj Fuleihan G, Bauer DC, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for
Bone and Mineral Research. J Bone Miner Res 2016; 31:16- 35. Erratum in: J Bone Miner Res 2016; 31:1910.
Hadji P, Aapro MS, Body JJ, et al. Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol. 2017 Mar 23; 7:1-12. doi:10.1016/j.jbo.2017.03.001.
Beaudoin C, Jean S, Moore L, et al. Number, location, and time since prior fracture as predictors of future fracture in the elderly from the general population. J Bone Miner Res
; 33:1956-66. CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 2017; 7:1-12.
Souza D, Barbalho M, Ramirez-Campillo R, Martins W, Gentil P. High and low-load resistance training produce similar effects on bone mineral density of middle-aged and
older people: a systematic review with meta-analysis of randomized clinical trials. Exp Gerontol 2020; 138:110973.
Zhang YP, Hu RX, Han M, et al. Evidence base of clinical studies on Qi Gong: a bibliometric analysis. Complement Ther Med 2020; 50:102392.
Shojaa M, von Stengel S, Kohl M, Schoene D, Kemmler W. Effects of dynamic resistance exercise on bone mineral density in postmenopausal women: a systematic review and meta-analysis with special emphasis on exercise parameters. Osteoporos Int 2020; 31:1427-44.
Cheong WF, Ji S, Cazenave-Gassiot A, et al. Predictors of circulating vitamin D levels in healthy mid-life Singaporean women. Arch Osteoporos 2021; 16:26.
Watson SL, Weeks BK, Weis LJ, et al. High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with
osteopenia and osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res. 2018 Feb; 33(2):211-220. doi: 10.1002/jbmr.3284.
Jackson RD, LaCroix AZ, Gass M, et al. Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354:669-83. Erratum in: N Engl J Med 2006; 354:1102.
National Institutes of Health. Datos sobre el calcio. [Internet] 2022. Citado el 6 de octubre de 2022. Disponible en: Http://Ods.Od.Nih.Gov
Fulgoni VL, Huth PJ, Dirienzo DB, Miller GD. Determinación del número óptimo de porciones lácteas para garantizar una baja prevalencia de ingesta inadecuada de calcio
en los estadounidenses. J Am Coll Nutr. 2004 Diciembre; 23(6):651-9. Doi: 10.1080/07315724.2004.10719407. PMID: 15637213
Shifren JL, Crandall CJ, Manson JE. Menopausal hormone therapy. JAMA 2019; 321:2458-9.
Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288:872-81.2.
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017; 24:728-53.
Pinkerton JV, Kaunitz AM, Manson JE. Concern about US Preventive Services Task Force recommendation on hormone therapy for the primary prevention of chronic conditions in postmenopausal women. Menopause 2018; 25:476.
Davey DA. Menopausal hormone therapy: a better and safer future. Climacteric 2018; 21:454-61.
Barrionuevo P, Kapoor E, Asi N, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 2019; 104:1623-30.
Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019; 364:k4810. Erratum in: BMJ 2019; 364:l162.
Khosla S, Hofbauer LC. Osteoporosis treatment: recen developments and ongoing challenges. Lancet Diabetes Endocrinol 2017; 5:898-907.
Brinton LA, Felix AS. Menopausal hormone therapy and risk of endometrial cancer. J Steroid Biochem Mol Biol 2014; 142:83-9.
Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013; 310:1353-68.
Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019; 394:1159-68.
Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015; (3):CD002229.
Formoso G, Perrone E, Maltoni S, et al. Short-term and long-term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev 2016; 10:CD008536.
Le Ray I, Dell’Aniello S, Bonnetain F, Azoulay L, Suissa S. Local estrogen therapy and risk of breast cancer recurrence
among hormone-treated patients: a nested case-control
study. Breast Cancer Res Treat 2012; 135:603-9.
Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16:15-23.
Anagnostis P, Paschou SA, Mintziori G, et al. Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement. Maturitas 2017; 101:23-30.
Cummings SR, San Martin J, McClung MR, et al. FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med2009; 361:756-65. Erratum in: N Engl J Med 2009; 361:1914.
Tsourdi E, Langdahl B, Cohen-Solal M, et al. Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 2017; 105:11-7.
Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344:1434-41.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
ARCHIVOS DE MEDICINA,SALUD Y EDUCACIÓN MÉDICA by Universidad Autónoma de Tamaulipas is licensed under a Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional License.
ARCIVOS DE MEDICINA, SALUD Y EDUCACIÓN MÉDICA es una revista digital de acceso abierto (OJS) y editada por la Universidad Autónoma de Tamaulipas, con publicación semestral Sitio web: ... Director de la revista:... Reserva de Derechos al Uso Exclusivo No..... otorgados por el Instituto Nacional del Derecho de Autor (INDAUTOR). Responsable de la última actualización Dr. José Alberto Ramírez de León, con domicilio en calle Matamoros S/N Zona Centro, C.P. 87000 Ciudad Victoria, Tamaulipas, México. Tels. (834) 3181800 y 3181700, ext 1148..
